These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14758817)

  • 21. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing.
    Goelen G; Rigo A; Bonduelle M; De Grève J
    J Clin Oncol; 1999 May; 17(5):1595-600. PubMed ID: 10334549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.
    Julian-Reynier C; Sobol H; Sévilla C; Noguès C; Bourret P;
    Psychooncology; 2000; 9(6):504-10. PubMed ID: 11180585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations.
    Reichelt JG; Dahl AA; Heimdal K; Møller P
    Dis Markers; 1999 Oct; 15(1-3):139-43. PubMed ID: 10595268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
    Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
    J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.
    Heimdal K; Maehle L; Apold J; Pedersen JC; Møller P
    Eur J Cancer; 2003 Oct; 39(15):2205-13. PubMed ID: 14522380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
    Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
    Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
    J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stigmatization and male identity: Norwegian males' experience after identification as BRCA1/2 mutation carriers.
    Strømsvik N; Råheim M; Oyen N; Engebretsen LF; Gjengedal E
    J Genet Couns; 2010 Aug; 19(4):360-70. PubMed ID: 20306122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
    Patenaude AF; Tung N; Ryan PD; Ellisen LW; Hewitt L; Schneider KA; Tercyak KP; Aldridge J; Garber JE
    Psychooncology; 2013 Sep; 22(9):2024-31. PubMed ID: 23417902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
    Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
    J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer.
    Claes E; Evers-Kiebooms G; Decruyenaere M; Denayer L; Boogaerts A; Philippe K; Legius E
    Behav Med; 2005; 31(3):93-105. PubMed ID: 16252621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing.
    Baars JE; Ausems MG; van Riel E; Kars MC; Bleiker EM
    J Genet Couns; 2016 Jun; 25(3):461-71. PubMed ID: 26446011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of testing for BRCA1/2 mutations in South East Scotland.
    Holloway SM; Bernhard B; Campbell H; Lam WW
    Eur J Hum Genet; 2008 Aug; 16(8):906-12. PubMed ID: 18285832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.